Variable | Risk category | Beta | HR | 95% CI | p-value |
---|---|---|---|---|---|
Sex | Male/female | 0.00 | 1.00 | (0.86-1.15) | 0.950 |
Age | >65 years/<65 years | −0.03 | 0.97 | (0.83-1.13) | 0.680 |
Site of primary tumour | Rectum/colon | 0.11 | 1.12 | (0.97-1.29) | 0.130 |
Primarily metastatic | M1/M0 | 0.29 | 1.34 | (1.14-1.56) | <0.001 |
Number of metastatic sites | 2/1 | 0.38 | 1.47 | (1.26-1.71) | <0.001 |
3 and more/1 | 0.66 | 1.94 | (1.57-2.39) | <0.001 | |
Chemotherapy regimen | XELOX/FOLFOX | −0.10 | 0.91 | (0.76-1.09) | 0.290 |